Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 1
1989 1
1990 1
1993 1
1994 2
1995 2
1996 1
1997 1
2001 1
2002 1
2003 2
2005 2
2006 6
2007 5
2008 4
2009 4
2010 6
2011 3
2012 4
2013 2
2017 2
2018 3
2020 1
2021 1
2023 1
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free PMC article. Clinical Trial.
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Leone G, Orlando F, Dutey-Magni P, Vainauskas O, Grist E, Ciani Y, Lall S, Thakali S, Wingate A, Wetterskog D, Sachdeva A, Sydes MR, McPhail N, Sreenivasan T, O'Sullivan JM, Clarke NW, Parmar MKB, Brown LC, James ND, Demichelis F, Attard G; STAMPEDE collaborators. Leone G, et al. JAMA Oncol. 2025 Feb 27;11(4):426-9. doi: 10.1001/jamaoncol.2024.7051. Online ahead of print. JAMA Oncol. 2025. PMID: 40014335
Diagnosis and Management of Subcoracoid Impingement.
McKernan MJ, Schickendantz MS, Frangiamore SJ. McKernan MJ, et al. J Am Acad Orthop Surg. 2021 Feb 1;29(3):100-107. doi: 10.5435/JAAOS-D-20-00008. J Am Acad Orthop Surg. 2021. PMID: 33323679
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Gillessen S, Murphy L, James ND, Sachdeva A, El-Taji O, Abdel-Aty H, Adler AI, Amos C, Attard G, Varughese M, Gale J, Brown S, Srihari N, Birtle AJ, Brown M, Chan K, Chowdhury S, Cross W, Dearnaley DP, Din O, Dutey-Magni P, Gilbert DC, Gilson C, Gray S, Grist E, Hofmann U, Hudson AM, Jain Y, Jeyasangar G, Jones R, Kayani M, Langley RE, Malik Z, Mason MD, Matheson D, McAlpine C, Macnair A, Millman R, Murphy C, Padden-Modi M, Parikh O, Parker C, Rush H, Russell M, Srinivasan R, Sundar S, Tanguay JS, Turco F, Williams P, Sydes MR, Parmar MKB, Brown LC, Clarke NW; STAMPEDE investigators. Gillessen S, et al. Lancet Oncol. 2025 Aug;26(8):1018-1030. doi: 10.1016/S1470-2045(25)00231-1. Epub 2025 Jul 7. Lancet Oncol. 2025. PMID: 40639383 Free PMC article. Clinical Trial.
Neutron spectrometry--an essential tool for diagnosing implosions at the National Ignition Facility (invited).
Gatu Johnson M, Frenje JA, Casey DT, Li CK, Séguin FH, Petrasso R, Ashabranner R, Bionta RM, Bleuel DL, Bond EJ, Caggiano JA, Carpenter A, Cerjan CJ, Clancy TJ, Doeppner T, Eckart MJ, Edwards MJ, Friedrich S, Glenzer SH, Haan SW, Hartouni EP, Hatarik R, Hatchett SP, Jones OS, Kyrala G, Le Pape S, Lerche RA, Landen OL, Ma T, MacKinnon AJ, McKernan MA, Moran MJ, Moses E, Munro DH, McNaney J, Park HS, Ralph J, Remington B, Rygg JR, Sepke SM, Smalyuk V, Spears B, Springer PT, Yeamans CB, Farrell M, Jasion D, Kilkenny JD, Nikroo A, Paguio R, Knauer JP, Glebov VY, Sangster TC, Betti R, Stoeckl C, Magoon J, Shoup MJ 3rd, Grim GP, Kline J, Morgan GL, Murphy TJ, Leeper RJ, Ruiz CL, Cooper GW, Nelson AJ. Gatu Johnson M, et al. Among authors: mckernan ma. Rev Sci Instrum. 2012 Oct;83(10):10D308. doi: 10.1063/1.4728095. Rev Sci Instrum. 2012. PMID: 23126835
Renal oncocytoma displaying intense activity on 18F-FDG PET.
Blake MA, McKernan M, Setty B, Fischman AJ, Mueller PR. Blake MA, et al. Among authors: mckernan m. AJR Am J Roentgenol. 2006 Jan;186(1):269-70. doi: 10.2214/AJR.05.0110. AJR Am J Roentgenol. 2006. PMID: 16357422 No abstract available.
63 results